Related Experiment Video
Updated: Dec 9, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Impending Cardiac Tamponade as the Initial Manifestation of BCR-ABL Positive Chronic Myeloid Leukemia
Safa Moursy1, Salem Gaballa1, Ameenjamal Ahmed1
1Internal Medicine, LewisGale Medical Center, Salem, USA.
Insights
This case report details a rare instance of hemorrhagic pericardial effusion in chronic myeloid leukemia. Therapeutic pericardiocentesis and hydroxyurea were crucial for managing cardiac tamponade before tyrosine kinase inhibitor therapy.
Area of Science:
- Hematology
- Oncology
- Cardiology
Background:
- Leukemic infiltration of the pericardium is common at autopsy.
- Clinically significant pericardial effusion leading to cardiac tamponade is a rare manifestation of leukemia.
- Patients with leukemia often have hemostatic abnormalities, increasing bleeding risks during interventions.
Observation:
- This report details a rare instance of hemorrhagic pericardial effusion in a patient with chronic myeloid leukemia (CML).
- The effusion occurred prior to the initiation of tyrosine kinase inhibitor (TKI) therapy.
Findings:
- The patient presented with cardiac tamponade due to leukemic pericardial effusion.
- Therapeutic pericardiocentesis was necessary to relieve the tamponade, posing a bleeding risk due to compromised hemostasis.
- The patient was treated with hydroxyurea and underwent pericardiocentesis.
Implications:
- This case underscores the importance of recognizing and managing rare complications like pericardial effusion in CML.
- Early intervention with procedures like pericardiocentesis and supportive treatments such as hydroxyurea may be crucial before definitive therapy.
- Further investigation into the mechanisms and optimal management of leukemic pericardial effusion is warranted.
Abstract:
Leukemia involves all organs and tissues of the body. Leukemic infiltration of the pericardium has been documented frequently at post-mortem examinations. Clinically, however, pericardial effusion with cardiac tamponade is rare, and only isolated case reports have been described. In all the reported cases, therapeutic pericardiocentesis was required for the relief of cardiac tamponade with the risk of bleeding since these patients often had deranged hemostasis. We are reporting a rare case of hemorrhagic pericardial effusion in chronic myeloid leukemia before starting the tyrosine kinase inhibitors. The patient required therapeutic pericardiocentesis and hydroxyurea treatment.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Introduction Cardiac Emergencies
Pulmonary Embolism I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Mitral Regurgitation I: Introduction